Article

Can Stem Cell Therapy Help Cerebral Palsy Patients?

Topic: Biofeedback and NeurofeedbackPublished May 5, 2019

Legacy signals

Legacy popularity: 1,067 legacy views

Cerebral palsy (CP) is an irreversible condition that affects children as well as their families. Though the condition is life-long, it is considered non-progressive. There are several potential causes of this condition, such as genetic factors, infection in the pregnant mother or fetus, underlying conditions in the fetus that may strain the birthing process, etc. It is considered to be a disorder of abnormalities in cognitive function and motor skills. No treatments have been found for CP, although some functional, nutritional supportive care, counseling, and social measures can be taken. As stated earlier, cerebral palsy is a condition that results in a permanent motor disability. Most times, the cause of CP can be traced to several issues in the brain during the development period of a child. Some children could also develop CP during pregnancy or childbirth due to a lack of oxygen, traumatic injury, infectious disorder, genetic condition or developmental abnormalities. The causes can be numerous if an injury to the brain occurred at different times of gestation. This makes the assessment and assigning of the right treatment for this condition very difficult. How can Stem Cells Treat Cerebral Palsy?rnStem cells can be used as a therapy for CP, particularly the ones derived from umbilical cord tissues. The blood-brain barrier (BBB) is what solely regulates the human brain. It is known as a semipermeable membrane; an organ in the brain that separates blood from cerebrospinal fluid. A few types of cells, molecules, and particles get into the brain through the mechanism of the BBB. These stem cells derived from umbilical cord tissues are special, and the reasons are listed below: 1. They can go across endothelial brain barrierrn2. Interaction with and alerting neighboring cells (Paracrine Effect)rn3. They trigger self-repair on existing cellsrn4. In a way, they regulate the immune system (Immunomodulation), thereby averting rejectionrn5. They reduce the possibility of inflammationrn6. They transform into neurons and gliarn7. Improvement in the formation of nerve cell axons (axogenesis) rnStem Cell Therapy and Cerebral PalsyrnSeven transfusions of these umbilical cord tissue stem cells were administered to a girl who suffered from cerebral palsy by a collaborative study between Chinese and American universities for six months in 2013. At the end of 28 months of monitoring her, it was observed that she encountered a few incidents of ambulatory tumbles and could sit upright by herself. Also, there was an improvement in her immune system.rnIt was reported in the year 2018 by the Chinese Academy of Medical Sciences that a 4-year-old boy with cerebral palsy was administered three doses of umbilical cord tissue stem cells. At the end of this treatment, brain improvement was observed through electroencephalogram (EEG) imaging, as well as improvements in limb motor strength, motor function, and language expression. ConclusionrnCerebral palsy, as stated earlier, is a condition that majorly affects children during their developmental period. It is known to be a permanent condition that can be managed through certain medications and physical therapies. However, stem cells offer an exciting opportunity to actually treat the cause of cerebral palsy, thereby improving the condition rather than simply managing symptoms. rnReferences: Cerebral palsy and stem cell treatments Can child International journal of stem cells Stem cell treatment now Birth injury guide Kids health Clinicaltrials.gov Cerebral palsy guide Cerebral palsy news today

Further reading

Further Reading

4 total

Article

The main focus of drug carrier research today is to identify carriers that are both safe and effective for clinical treatment applications. As treatment strategies advance researchers regularly update drug delivery systems. Traditional drug delivery systems consist of liposomes and polymer micelles together with nanoparticles but despite their inclusion in clinical trials current versions still encounter limitations. Liposomes struggle to release hydrophobic drugs from their

March 26, 2025

Article

Traditional immunoassays based on the format of 96-well microtiter plates are widely used in analytical laboratories and have become increasingly automated with the introduction of robotics technology in recent years, thereby enhancing assay throughput. Most clinical analyzers essentially operate as "stand-alone laboratories," featuring precise, accurate, and highly reproducible programmatic liquid handling, sample addition, and washing steps. However, aside from cost, the si

March 26, 2025

Article

The History of ADC Drugs ADC drug history begins with "magic bullet". Physicians have long had high cytotoxic chemotherapy drugs for tumour treatment. As they target cancer cells, chemotherapeutics will also random attack healthy cells and become systemically toxic. Paul Ehrlich came up with the term "magic bullet" in 1913. He pictured fitting chemotherapy drugs on carriers that would shoot to tumour cells – as they do with missiles – to send them to tumor tissue so that

March 26, 2025

Article

The primary function of atrial natriuretic peptide ( ANP/a>) includes regulation of water and salt metabolism together with vascular volume which helps control blood pressure stability. Additionally, ANP manages endothelial cell permeability and counters the adrenal aldosterone system which allows it to control growth metabolism and influence myocardial hypertrophy and fibrosis regulation. Recent research shows that ANP and its receptors are present in several immune cells an

March 26, 2025